Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Anova Enterprises, Inc.

News headline image
Anova Expands Platform With Launch of Next-Generation eTMF Solution for Sponsors, CROs, and Research Sites
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Five Hundredth Urology Research Site Joins Anova’s Global Urology Research Network
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Launches Free AI-enabled Clinical Trial Patient Matching Solution as Part of a Global Just-in-time Research Network
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Today Announced the Enrollment of 550+ Patients at 50+ Sites in Six Months for a Single Study
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Launches Global Clinical Registry to Accelerate Research and Access to Promising New Treatments
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Announces First Patient Enrolled to Phase 1/2a Study of DB107 for the Treatment of High-Grade Gliomas
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Expands Leadership Team to Manage Growth and Drive Innovation
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Partners with Dizal (Jiangsu) Pharmaceuticals to Accelerate Development of DZD9008 for Patients with Advanced or Metastatic NSCLC with EGFR Exon20 insertion Mutation
From Anova Enterprises, Inc.
Via Business Wire
News headline image
United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova and Mary Crowley Cancer Research Announce a Partnership to Bring New Treatments to Cancer Patients in Need
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Anova Launches Global Patient Registry Study to Better Understand Clinical Trials and Patient Outcomes
From Anova Enterprises, Inc.
Via Business Wire
News headline image
Hundreds Of Patients Benefit From Access To Promising Treatments For Complex And Rare Disease Using AnovaOS™
From Anova Enterprises, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.